Trial
NCT00667953
Study of Temzolomide and Gleevec in Advanced Melanoma
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Abramson Cancer Center at Penn Medicine
Collaborators
Novartis Pharmaceuticals
Condition
Melanoma
Intervention
Gleevec
Why stopped
Difficulty enrolling subjects
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-03-30